The Pharmacovigilance drug safety software market was $1506.26 million in the year 2022 and is projected to attain $2544.36 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 6% throughout the forecasted period. Pharmaceutical companies, contract research organizations (CROs), and regulatory authorities make use of pharmacovigilance drug safety software to monitor and evaluate...